Lumley rolls out new risk product
LIFE insurance group Lumley has launched a new critical illness product in an effort to tackle the issue of the rising costs of trauma insurance.
The new product, simply named Lumley Critical Illness Insurance, will differ from existing life insurance products by seeking to provide tighter definitions of critical illnesses that trigger insurance policy pay outs, according to Lumley director and deputy chief executive Frank Smith.
“At present, a person can have a minor heart attack and receive a full pay out, but there are problems with this type of product because premiums are not sustainable as incident claims increase,” Smith says.
“The only other option has been to drop the level of cover in the insurance product, but with a tighter definition of what is a critical illness, we can maintain the cover and remain affordable.”
The policy will do this by limiting the initial pay out to 25 per cent of the insured amount on diagnosis.
However, if the medical condition worsens, such as a second heart attack or spreading of a cancer, then the remaining 75 per cent will also be paid to the insured.
The group took two years to adequately create the new non-subjective definitions used in the policy, according to Smith.
The research was carried out in conjunction with actuaries, reinsurers, medical specialists and financial planners.
AUTHOR
Jason Spits
Recommended for you
Remediation and litigation costs have led AMP to announce a reduced statutory net profit after tax of $98 million for the first half of 2025.
Stakeholders in the professional year discussion underscore the challenges in the current pipeline and what is holding back licensees from taking on new candidates.
Colonial First State has partnered with JP Morgan Asset Management to make its inaugural private equity allocation, continuing the firm’s expansion into unlisted asset classes.
Two law firms have highlighted licensees’ responsibility to ensure they have sufficient cyber security measures in light of the enforcement action against Fortnum Private Wealth.
